Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
Full conference information obtained from the Annual cancer conference program and abstracts. See ID# 15548. (QZ200 B366 2006); Welcome by Dr. Simon Sutcliffe (10 minutes); Lymphoma on two continents : what have we learned (60 minutes)
c.1 BC Cancer Agency VAN Library AV Room | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
Designed to educate patients and the public about the basics and new treatments for lymphoid cancer, which includes non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma, chronic lymphocytic leukemia and Waldenstrom's macroglobulinemia.; Opening remarks by Dr. Max Coppes; Lymphoid cancer : myths…
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.2 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency PG Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency KEL Cancer Info Ctr | Available | ||
c.2 BC Cancer Agency KEL Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.2 BC Cancer Agency VAN Library | Available |
Designed to educate patients and the public about the basics and new treatments for lymphoid cancer, which includes non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma, chronic lymphocytic leukemia and Waldenstrom's macroglobulinemia.; Speakers:; Dr. Joseph Connors - "Lymphoid cancer basics"; …
c.1 BC Cancer Agency VAN Library Archives | Available |
Table of Contents:; Introduction; Here to help; Your child - the initial diagnosis; Your child - coping with change; Parents - coming to terms with your feelings; Siblings - helping them cope too; Communicating with your extended family and friends; The new normal; More information
Designed to educate patients and the public about the basics and new treatments for lymphoid cancer, which includes non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma, chronic lymphocytic leukemia and Waldenstrom's macroglobulinemia.; Lymphoma cancer basics by Dr. Joseph Connors; Wonderful wo…
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.2 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency KEL Cancer Info Ctr | Available | ||
c.2 BC Cancer Agency KEL Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.2 BC Cancer Agency VAN Library | Available |
Designed to educate patients and the public about the basics and new treatments for lymphoid cancer, which includes non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma, chronic lymphocytic leukemia and Waldenstrom's macroglobulinemia.; Basics of lymphoid cancer : what are they and how are they…
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.2 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency KEL Cancer Info Ctr | Available | ||
c.2 BC Cancer Agency KEL Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.2 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | On Loan, due Monday, June 10, 2024 | ||
c.1 BC Cancer Agency PG Cancer Info Ctr Missing | Available |
c.2 BC Cancer Agency VAN Library | Available | ||
c.3 BC Cancer Agency VAN Library | Available |
Designed to educate patients and the public about the basics and new treatments for lymphoid cancer, which includes non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma, chronic lymphocytic leukemia and Waldenstrom's macroglobulinemia.; Lymphoid cancer 101 : the basics by Dr. Joseph Connors; Ne…
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.2 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency KEL Cancer Info Ctr | Available | ||
c.2 BC Cancer Agency KEL Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.2 BC Cancer Agency VAN Library | Available |
c.2 BC Cancer Agency VIC Cancer Info Ctr | On Loan, due Tuesday, February 20, 2024 | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency PG Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency SUR Cancer Info Ctr Missing | Available | ||
c.1 BC Cancer Agency VAN Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VIC Cancer Info Ctr Missing | Available |
c.1 BC Cancer Agency KEL Cancer Info Ctr | Available |
c.1 BC Cancer Agency VAN Cancer Info Ctr | Available |
c.1 BC Cancer Agency VIC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency SUR Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VAN Cancer Info Ctr | Available | ||
c.2 BC Cancer Agency PG Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency PG Cancer Info Ctr Missing | Available |
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available |
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Cancer Info Ctr | Available | ||
c.2 BC Cancer Agency VIC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency KEL Cancer Info Ctr | Available |
c.1 BC Cancer Agency VIC Cancer Info Ctr | Available | ||
c.2 BC Cancer Agency VIC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency PG Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency KEL Cancer Info Ctr | Available |
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency PG Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency SUR Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Cancer Info Ctr | Available | ||
c.2 BC Cancer Agency VAN Cancer Info Ctr | Available | ||
c.2 BC Cancer Agency ARHCC Cancer Info Ctr | Available |
"Clinical and preclinical exploration of gene and cellular immunotherapy have seen rapid growth and interest with the development and approval of five Chimeric Antigen Receptor T-cell (CAR-T) products for lymphoma and myeloma and one Bispecific T-Cell Engager (BiTE) for acute lymphoblastic leukemia…